ロード中…
The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial
BACKGROUND: Mild cognitive impairment (MCI) is an intermediate phase between normal aging and dementia. Since a majority of amnestic MCI (aMCI) cases progress to Alzheimer’s disease (AD), it is considered the prodromal stage of AD and, therefore, a treatment target for the prevention of further cogn...
主要な著者: | , , , , , , |
---|---|
フォーマット: | Online 論文 テキスト |
言語: | English |
出版事項: |
BioMed Central
2019
|
主題: | |
オンライン・アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647292/ https://www.ncbi.nlm.nih.gov/pubmed/31331367 http://dx.doi.org/10.1186/s13063-019-3567-1 |